1-Amino-5-phosphonoindan-1-carboxylic acid
1-Amino-5-phosphonoindan-1-carboxylic acid (APICA) is a chemical compound that acts as a selective antagonist of the metabotropic glutamate receptor subtype mGluR2 and mGluR3. It is primarily used in scientific research to study the role of these receptors in the central nervous system.
Chemical Structure and Properties
1-Amino-5-phosphonoindan-1-carboxylic acid is an indane derivative, characterized by the presence of an indan ring system with an amino group, a phosphono group, and a carboxylic acid group. The chemical formula of APICA is C10H12NO5P, and it has a molecular weight of 257.18 g/mol.
The compound is a white to off-white crystalline powder that is soluble in water and other polar solvents. The presence of both the phosphono and carboxylic acid groups makes it a zwitterionic compound, which can affect its solubility and interaction with biological molecules.
Pharmacological Action
APICA functions as an antagonist at the mGluR2 and mGluR3 receptors, which are part of the group II metabotropic glutamate receptors. These receptors are G-protein coupled receptors that modulate neurotransmission in the brain. By blocking these receptors, APICA can inhibit the effects of glutamate, the primary excitatory neurotransmitter in the brain.
The blockade of mGluR2 and mGluR3 by APICA has been shown to affect various neurological processes, including synaptic plasticity, learning, and memory. This makes APICA a valuable tool in neuroscience research for understanding the role of glutamate signaling in these processes.
Applications in Research
APICA is used extensively in preclinical studies to investigate the function of mGluR2 and mGluR3 receptors. It has been employed in studies exploring the pathophysiology of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, as well as in research on psychiatric disorders like schizophrenia and depression.
By using APICA to selectively block mGluR2 and mGluR3, researchers can better understand the contribution of these receptors to disease states and evaluate the potential of targeting these receptors for therapeutic intervention.
Safety and Handling
As with many research chemicals, APICA should be handled with care in a laboratory setting. Appropriate safety measures, including the use of personal protective equipment and proper ventilation, should be employed to minimize exposure. The compound should be stored in a cool, dry place, away from light and moisture to maintain its stability.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD